Litcius/Paper detail

Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis

Hui‐Teng Cheng, Hsi‐Chien Huang, Tsung‐Ying Lee, Yuhui Liao, Yi-Hua Sheng, Pei-Ru Jin, Kuan‐Wei Huang, Ling-Hsuan Chen, Yi‐Ting Chen, Ziyan Liu, Tzu‐Chieh Lin, Hsueh‐Cheng Wang, Cheng‐Han Chao, I. Pu Juang, Chi-Ting Su, Kuo‐How Huang, Shuei‐Liong Lin, Jane Wang, Yun‐Chieh Sung, Yunching Chen

2022Journal of Controlled Release31 citationsDOI

Topics & Concepts

MyofibroblastSorafenibHoming (biology)FibrosisCancer researchDrug deliveryKidneyMedicineIn vivoPharmacologyChemistryPathologyInternal medicineBiologyHepatocellular carcinomaOrganic chemistryBiotechnologyEcologyMuscle and Compartmental DisordersRenal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis | Litcius